A nurse enters a client's room to administer medication and finds the client lying in bed disoriented with labored and fast respirations. Which of the following actions should the nurse take first?

A. Instruct the client to use a pursed-lip breathing technique.

Pursed-lip breathing is a technique commonly used to help relieve dyspnea, particularly in individuals with COPD. This technique involves breathing in through the nose and exhaling slowly through pursed lips, which helps to prolong exhalation, reduce airway collapse, and improve oxygen exchange. While pursed-lip breathing can be beneficial, it should not be the priority action when the client reports difficulty breathing. Before initiating any breathing techniques, the nurse should first assess the client's respiratory status to determine the severity of the breathing difficulty and whether additional interventions are necessary.

B. Evaluate the client's respiratory status.

This is the correct priority action in this scenario. When a client with COPD reports difficulty breathing, the nurse's first step should be to thoroughly assess the client's respiratory status. This assessment involves evaluating respiratory rate, depth, effort, oxygen saturation levels, auscultating lung sounds, and assessing for signs of respiratory distress. By conducting a comprehensive assessment, the nurse can determine the severity of the client's symptoms, identify any potential exacerbating factors or complications, and make informed decisions regarding appropriate interventions.

C. Increase the oxygen flow to 3 L/min.

While increasing the oxygen flow may be a consideration if the client's oxygen saturation is low, it should not be the immediate priority without first assessing the client's respiratory status. Increasing oxygen flow without proper assessment could potentially worsen hypercapnia in some COPD patients and may not address the underlying cause of the client's difficulty breathing. Therefore, this action should be based on assessment findings rather than being the initial response.

D. Have the client cough and expectorate secretions.

Coughing and expectorating secretions can be helpful in clearing the airways and improving breathing in individuals with COPD, especially if secretions are contributing to the difficulty breathing. However, similar to the pursed-lip breathing technique, this action should not be the priority without first assessing the client's respiratory status. The nurse should determine whether secretions are indeed present and causing the difficulty breathing before instructing the client to cough and expectorate. Therefore, this option should follow a thorough respiratory assessment.

A. Liver function tests

This is the correct choice. Pyrazinamide, a medication used in the treatment of tuberculosis, is known to potentially cause hepatotoxicity, which refers to liver damage or dysfunction. Therefore, clients prescribed pyrazinamide should undergo regular monitoring of liver function tests to assess for any signs of liver injury or impairment. Liver function tests typically include measurements of various enzymes and proteins produced by the liver, such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and bilirubin levels.

B. Gallbladder studies

Gallbladder studies are not typically indicated for clients taking pyrazinamide. While pyrazinamide can rarely cause hepatotoxicity, which may affect liver function, it is not known to specifically target or affect the gallbladder. Therefore, routine gallbladder studies are not necessary for clients taking pyrazinamide.

C. Thyroid function studies

Pyrazinamide is not known to directly affect thyroid function. Therefore, routine thyroid function studies are not indicated for clients taking pyrazinamide unless there are specific signs or symptoms suggesting thyroid dysfunction.

D. Blood glucose levels

Pyrazinamide is not known to directly affect blood glucose levels. Therefore, routine monitoring of blood glucose levels is not indicated for clients taking pyrazinamide unless there are specific reasons to suspect or monitor for diabetes mellitus or other conditions affecting blood glucose regulation.